Mico BioMed Reports Operating Loss of 19.3 Billion KRW Last Year... Continued Deficit
Mico Biomed announced that its operating loss last year was 19.3 billion KRW, continuing its deficit. The net loss for the period was 25.7 billion KRW.
Hot Picks Today
"Why Is the Amount in My Account So Low?"... Why Pension Savings Subscribers Were Surprised
- "Even Lee Jae-yong may not be this big a fan"... Stunned to See Galaxy Phones in a Taxi
- KOSPI recovers previous day's losses, rises more than 3%; KOSDAQ also gains 1.4%
- "After Sleeping Well with Strangers"... Who Is the 24-Year-Old Woman Who Won 19 Million Won?
- "I wanted her to feel my passionate love"... Wife collapses after husband's overly tight hug, diagnosed with broken ribs
The company explained that sales in the molecular diagnostics sector (PCR devices and reagents, etc.) and the immunodiagnostics sector (RDT kits, etc.) decreased due to the transition to the COVID-19 endemic phase.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
![[Editorial] Semiconductor Labor Exceptions: Don't Hide Behind Social Dialogue](https://cwcontent.asiae.co.kr/asiaresize/307/2026091511203728817_1789438836.jpg)
![[Editorial] Reviving the Special Inspector Is Only the Beginning... Authority and Scope Must Be Expanded](https://cwcontent.asiae.co.kr/asiaresize/307/2026091810333133998_1789695212.jpg)
